XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.
E
E

Ecolab

Yangiliklar

Reuters - 1 hafta oldin

U.S. Cintas, Nasdaq, Talen Energy

U.S. RESEARCH ROUNDUP-Cintas, Nasdaq, Talen Energy Sept 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cintas, Nasdaq and Talen Energy, on Thursday. HIGHLIGHTS * Celldex Therapeutics Inc CLDX.O : Wells Fargo raises to overweight from equal weight * Cintas Corp CTAS.O : JP Morgan raises target price to $228 from $212.50 * Expedia Group Inc EXPE.O : TD Cowen cuts to hold from buy * Nasdaq Inc NDAQ.O : TD Cowen init
C
C
E
M
N
F
E
G
C
F
Reuters - 3 hafta oldin

U.S. Avalonbay Communities, Elf Beauty, Evercore

U.S. RESEARCH ROUNDUP-Avalonbay Communities, Elf Beauty, Evercore Sept 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avalonbay Communities, Elf Beauty and Evercore on Monday. HIGHLIGHTS * Avalonbay Communities Inc AVB.N : JP Morgan raises target price to $247 from $212 * Colgate-Palmolive Co CL.N : Wells Fargo cuts to underweight from equal-weight * Elf Beauty Inc ELF.N : Piper Sandler cuts target price to $162
C
G
G
I
C
E
E
C
Reuters - 2 oy oldin

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C
Reuters - 2 oy oldin

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5)

CORRECTED-U.S. RESEARCH ROUNDUP-Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5) Corrects U.S. research roundup dated Aug. 5 to remove dated research actions from headline and tables, the errors appeared in previous versions also Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday.
A
A
B
I
M
P
A
A
E
A
E
I
A
A
A
A
F
G
H
L
L
Reuters - 2 oy oldin

Ecolab misses second-quarter sales estimates, shares slump

Ecolab misses second-quarter sales estimates, shares slump July 30 (Reuters) - Ecolab ECL.N reported second-quarter sales on Tuesday that missed analysts' estimates, sending the water solutions company's shares down nearly 8%. The negative stock reaction is a combination of lower-than-expected quarterly sales and investors' more ambitious earnings growth expectations in the context of more lofty valuation metrics, Vertical Research Partners analyst Kevin McCarthy said.
E
Reuters - 2 oy oldin

Ecolab Q2 Adjusted EPS USD 1.68 Vs. IBES Estimate USD 1.67

BRIEF-Ecolab Q2 Adjusted EPS USD 1.68 Vs. IBES Estimate USD 1.67 Jul 30 (Reuters) - Ecolab Q2 net income USD 490.9 million. Q2 sales USD 3,985.8 million vs. IBES estimate USD 4,028 million Q2 operating income USD 656.9 million Q2 EPS USD 1.71 outlook FY adjusted EPS USD 6.5-6.7 outlook Q3 adjusted EPS USD 1.75-1.85
E
Reuters - 2 oy oldin

Microsoft and job openings to hit pre-Fed vigil

MORNING BID AMERICAS-Microsoft and job openings to hit pre-Fed vigil A look at the day ahead in U.S. and global markets from Mike Dolan To the extent that worries about pricey tech stocks and rising AI capex spending were partly behind last week's market shakeout, Microsoft's quarterly update should prove a key moment later on Tuesday, just as the Federal Reserve's latest policy meeting gets under way.
A
A
E
G
I
M
M
N
P
S
U
A
G
J
U
U
U
F
E
E
S
A
H
L
Reuters - 2 oy oldin

What to Watch in the Day Ahead - Tuesday, July 30

What to Watch in the Day Ahead - Tuesday, July 30 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Microsoft is expected to report a rise in fourth-quarter revenue on robust demand for its AI-powered cloud and business software offerings.
M
M
M
P
Q
S
S
E
E
L
Reuters - 2 oy oldin

Ecolab Inc <ECL.N> expected to post earnings of $1.67 a share - Earnings Preview

Ecolab Inc expected to post earnings of $1.67 a share - Earnings Preview Ecolab Inc ECL.N , ECL is expected to show a rise in quarterly revenue when it reports results on July 30 for the period ending June 30 2024 The Saint Paul Minnesota-based company is expected to report a 4.6% increase in revenue to $4.028 billion from $3.85 billion a year ago, according to the mean estimate from 18 analysts, based on LSEG data.
E

Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.